Evolus

Evolus Diluted EPS

The Diluted Earnings per Share of Evolus (EOLS) as of Nov 2, 2026 is -0.80 USD. In the previous year, Diluted Earnings per Share was -0.80 USD — a change of 0.67% (lower).

Diluted EPS

-0.80USD

YoY

0.67%

Last updated:

Diluted Earnings per Share of Evolus is 2025 -0.80 USD. Diluted Earnings per Share of Evolus was 2024 -0.80 USD. It decreases by 0.67% lower compared to the previous year.

The Evolus Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-1.72 USD
Jan 1, 2019
-2.93 USD
Jan 1, 2020
-4.83 USD
Jan 1, 2021
-0.84 USD
Jan 1, 2022
-1.32 USD
Jan 1, 2023
-1.08 USD
Jan 1, 2024
-0.80 USD
Jan 1, 2025
-0.80 USD
The Evolus Diluted EPS history
YEARDiluted EPSYoY
-0.80USD+0.67%
-0.80USD-26.16%
-1.08USD-18.52%
-1.32USD+57.01%
-0.84USD-82.56%
-4.83USD+64.77%
-2.93USD+70.91%
-1.72USD+611.83%
-0.24USD-77.67%
-1.08USD-41.03%
-1.83USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Diluted Earnings per Share of Evolus is -0.80 USD in 2025.

Diluted Earnings per Share of Evolus changed from -0.80 USD to -0.80 USD, representing a 0.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Evolus since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Evolus

All Key Metrics — Evolus